AACR ANNUAL MEETING 2024, Apr 7-10
KACTUS is thrilled to announce our participation in the prestigious American Association for Cancer Research® (AACR) Annual Meeting 2024, takin...
Read moreRational, thoughtful decisions based on structural analysis are the foundation for our SAMS protein engineering platform. All of our catalog products undergo rigorous design testing to ensure natural protein configurations and optimized activity.
FEATURED COLLECTION
150+ catalog products with various alleles, peptides, fluorophores, & tetramers.
Stabilized peptide-free MHCs designed for loading your neoantigen peptides in-house.
Custom expression of soluble TCRs and MHC/TCR binding analysis.
Full-length multi-pass transmembrane proteins for antibody drug discovery and development.
FEATURED COLLECTION
With a full portfolio of mRNA production enzymes and gene editing enzymes, KACTUS accelerates your transition from preclinical studies to commercial manufacturing, ensuring a seamless and efficient pathway to market readiness.
Using our SAMS Technology platform, KACTUS specializes in protein engineering and expression optimization tailored for both routine and difficult-to-express proteins. Our diverse range of expression systems includes HEK293, CHO, E. coli, and yeast cells. Customization is at the heart of our service. Whether you require specific tags, fluorescent labels, or biotinylation, we're equipped to cater to your specific experimental needs. Our scientific team will assist you with protein structure optimization specific to your application.
→ Carefully selected catalog products based on unmet market needs
→ Customization options to meet innovative drug development demands
→ Large and continuously expanding catalog
→ Structure Aided Design and Multiplex Screening (SAMS)
→ Optimized protein sequence and 3D structure
→ Expression condition testing specific to each product and cell line
→ Tested for purity and bioactivity
→ Control over endotoxin, host cell protein, & other contaminants
→ Comprehensive suite of analytical equipment including SPR, HPLC, Mass Spec, etc.
KACTUS is thrilled to announce our participation in the prestigious American Association for Cancer Research® (AACR) Annual Meeting 2024, takin...
Read moreSince December 2023, there have been several positive updates about drugs targeting MSLN. On December 19th, RemeGen announced that the U.S. FDA has...
Read more